aTYR PHARMA INC — Director's Dealing 2021

Sep 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: aTYR PHARMA INC (LIFE)
CIK: 0001339970
Period of Report: 2021-09-20

Reporting Person: SCHIMMEL PAUL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-20	Common Stock	P	250000	$8.00	Acquired	252890	Direct
2021-09-20	Common Stock	G	250000	$0.00	Disposed	2890	Direct
2021-09-20	Common Stock	G	250000	$0.00	Acquired	679143	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	113023	Indirect

Footnotes

F1: Represents shares purchased in an underwritten public offering at a public offering price of $8.00 per share.

F2: These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.

F3: These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel.